Apixaban Impurity 84 | CAS 2816305-40-3 - Request Quote
Apixaban Impurity 84
| SZ CAT No: | SZ-A062119 |
| CAS No | 2816305-40-3 |
| Mol.F. | C15H17N3O2 |
| Mol.Wt. | 271.3 |
| Inv. Status | Synthesis on demand |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
CHNS Ratio (%) :
Usage Note:
Apixaban Impurity 84 is chemically 1-(4-Aminophenyl)-3-morpholinopyridin-2(1H)-one. Apixaban Impurity 84 is supplied with detailed characterization data compliant with regulatory guideline. Apixaban Impurity 84 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Apixaban.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2816305-40-3
Purchase 2816305-40-3
Order 2816305-40-3
Enquire 2816305-40-3
price of 2816305-40-3
2816305-40-3 Supplier
2816305-40-3 Manufacturer
2816305-40-3 Exporter
buy high quality Apixaban Impurity 84
Purchase Apixaban Impurity 84
Apixaban Impurity 84 suppliers
Apixaban Impurity 84 manufacturers
Apixaban Impurity 84 price
Order Apixaban Impurity 84
Enquire Apixaban Impurity 84
Apixaban Impurity 84 cost
Apixaban Impurity 84 Supplier
Apixaban Impurity 84 Distributor
Apixaban Impurity 84 for Method Validation
Apixaban Reference Standard
Apixaban Impurity 84 for ANDA Filing
Apixaban Impurity 84 for Forced Degradation Studies
Apixaban Impurity 84 Identification Standards
Apixaban Impurity 84 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.